 | • レポートコード：MRC2-11QY05083 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウィルソン病治療のグローバル市場について調査・分析したレポートです。種類別（D-ペニシラミン、トリエンチン、テトラチオモリブデン酸塩、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウィルソン病治療の競争状況、市場シェア ・世界のウィルソン病治療市場：種類別市場規模 2015年-2020年（D-ペニシラミン、トリエンチン、テトラチオモリブデン酸塩、その他） ・世界のウィルソン病治療市場：種類別市場規模予測 2021年-2026年（D-ペニシラミン、トリエンチン、テトラチオモリブデン酸塩、その他） ・世界のウィルソン病治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のウィルソン病治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のウィルソン病治療市場分析：米国、カナダ ・ヨーロッパのウィルソン病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウィルソン病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウィルソン病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウィルソン病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Valeant Pharmaceuticals International. Inc.、Tsumura & Co、Merck & Co、VHB Life Science Inc.、Teva Pharmaceuticals USA, Inc、Wilson's Therapeutics AB、Noble Pharma Co., Ltd、Kadmon Holding, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Wilson’s Disease Treatment Market
The global Wilson’s Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Wilson’s Disease Treatment Scope and Market Size
Wilson’s Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wilson’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Valeant Pharmaceuticals International. Inc.
Tsumura & Co
Merck & Co
VHB Life Science Inc.
Teva Pharmaceuticals USA, Inc
Wilson’s Therapeutics AB
Noble Pharma Co., Ltd
Kadmon Holding, Inc.
Market segment by Type, the product can be split into
D-Penicillamine
Trientine
Tetrathiomolybdate
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Wilson’s Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Wilson’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 D-Penicillamine
1.4.3 Trientine
1.4.4 Tetrathiomolybdate
1.4.5 Others
1.5 Market by Application
1.5.1 Global Wilson’s Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Wilson’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Wilson’s Disease Treatment Growth Trends by Regions
2.2.1 Wilson’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Wilson’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Wilson’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Wilson’s Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Wilson’s Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Wilson’s Disease Treatment Players by Market Size
3.1.1 Global Top Wilson’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Wilson’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Wilson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Wilson’s Disease Treatment Market Concentration Ratio
3.2.1 Global Wilson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Wilson’s Disease Treatment Revenue in 2019
3.3 Wilson’s Disease Treatment Key Players Head office and Area Served
3.4 Key Players Wilson’s Disease Treatment Product Solution and Service
3.5 Date of Enter into Wilson’s Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Wilson’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Wilson’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Wilson’s Disease Treatment Market Size by Application (2015-2020)
5.2 Global Wilson’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Wilson’s Disease Treatment Market Size (2015-2020)
6.2 Wilson’s Disease Treatment Key Players in North America (2019-2020)
6.3 North America Wilson’s Disease Treatment Market Size by Type (2015-2020)
6.4 North America Wilson’s Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Wilson’s Disease Treatment Market Size (2015-2020)
7.2 Wilson’s Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Wilson’s Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Wilson’s Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Wilson’s Disease Treatment Market Size (2015-2020)
8.2 Wilson’s Disease Treatment Key Players in China (2019-2020)
8.3 China Wilson’s Disease Treatment Market Size by Type (2015-2020)
8.4 China Wilson’s Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Wilson’s Disease Treatment Market Size (2015-2020)
9.2 Wilson’s Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Wilson’s Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Wilson’s Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Wilson’s Disease Treatment Market Size (2015-2020)
10.2 Wilson’s Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Wilson’s Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Wilson’s Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Wilson’s Disease Treatment Market Size (2015-2020)
11.2 Wilson’s Disease Treatment Key Players in India (2019-2020)
11.3 India Wilson’s Disease Treatment Market Size by Type (2015-2020)
11.4 India Wilson’s Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Wilson’s Disease Treatment Market Size (2015-2020)
12.2 Wilson’s Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Wilson’s Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Wilson’s Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Valeant Pharmaceuticals International. Inc.
13.1.1 Valeant Pharmaceuticals International. Inc. Company Details
13.1.2 Valeant Pharmaceuticals International. Inc. Business Overview
13.1.3 Valeant Pharmaceuticals International. Inc. Wilson’s Disease Treatment Introduction
13.1.4 Valeant Pharmaceuticals International. Inc. Revenue in Wilson’s Disease Treatment Business (2015-2020))
13.1.5 Valeant Pharmaceuticals International. Inc. Recent Development
13.2 Tsumura & Co
13.2.1 Tsumura & Co Company Details
13.2.2 Tsumura & Co Business Overview
13.2.3 Tsumura & Co Wilson’s Disease Treatment Introduction
13.2.4 Tsumura & Co Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.2.5 Tsumura & Co Recent Development
13.3 Merck & Co
13.3.1 Merck & Co Company Details
13.3.2 Merck & Co Business Overview
13.3.3 Merck & Co Wilson’s Disease Treatment Introduction
13.3.4 Merck & Co Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.3.5 Merck & Co Recent Development
13.4 VHB Life Science Inc.
13.4.1 VHB Life Science Inc. Company Details
13.4.2 VHB Life Science Inc. Business Overview
13.4.3 VHB Life Science Inc. Wilson’s Disease Treatment Introduction
13.4.4 VHB Life Science Inc. Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.4.5 VHB Life Science Inc. Recent Development
13.5 Teva Pharmaceuticals USA, Inc
13.5.1 Teva Pharmaceuticals USA, Inc Company Details
13.5.2 Teva Pharmaceuticals USA, Inc Business Overview
13.5.3 Teva Pharmaceuticals USA, Inc Wilson’s Disease Treatment Introduction
13.5.4 Teva Pharmaceuticals USA, Inc Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.5.5 Teva Pharmaceuticals USA, Inc Recent Development
13.6 Wilson’s Therapeutics AB
13.6.1 Wilson’s Therapeutics AB Company Details
13.6.2 Wilson’s Therapeutics AB Business Overview
13.6.3 Wilson’s Therapeutics AB Wilson’s Disease Treatment Introduction
13.6.4 Wilson’s Therapeutics AB Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.6.5 Wilson’s Therapeutics AB Recent Development
13.7 Noble Pharma Co., Ltd
13.7.1 Noble Pharma Co., Ltd Company Details
13.7.2 Noble Pharma Co., Ltd Business Overview
13.7.3 Noble Pharma Co., Ltd Wilson’s Disease Treatment Introduction
13.7.4 Noble Pharma Co., Ltd Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.7.5 Noble Pharma Co., Ltd Recent Development
13.8 Kadmon Holding, Inc.
13.8.1 Kadmon Holding, Inc. Company Details
13.8.2 Kadmon Holding, Inc. Business Overview
13.8.3 Kadmon Holding, Inc. Wilson’s Disease Treatment Introduction
13.8.4 Kadmon Holding, Inc. Revenue in Wilson’s Disease Treatment Business (2015-2020)
13.8.5 Kadmon Holding, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Wilson's Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Wilson's Disease Treatment Revenue
Table 3. Ranking of Global Top Wilson's Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Wilson's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of D-Penicillamine
Table 6. Key Players of Trientine
Table 7. Key Players of Tetrathiomolybdate
Table 8. Key Players of Others
Table 9. Global Wilson's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Wilson's Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Wilson's Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Wilson's Disease Treatment Market Share by Regions (2015-2020)
Table 13. Global Wilson's Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Wilson's Disease Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Wilson's Disease Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Wilson's Disease Treatment Players
Table 20. Global Wilson's Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Wilson's Disease Treatment Market Share by Players (2015-2020)
Table 22. Global Top Wilson's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Treatment as of 2019)
Table 23. Global Wilson's Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Wilson's Disease Treatment Product Solution and Service
Table 26. Date of Enter into Wilson's Disease Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Wilson's Disease Treatment Market Size Share by Type (2015-2020)
Table 30. Global Wilson's Disease Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Wilson's Disease Treatment Market Size Share by Application (2015-2020)
Table 32. Global Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Wilson's Disease Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 36. North America Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 38. North America Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 42. Europe Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 44. Europe Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 48. China Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 50. China Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 54. Japan Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 56. Japan Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 60. Southeast Asia Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 66. India Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 68. India Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Wilson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Wilson's Disease Treatment Market Share (2019-2020)
Table 72. Central & South America Wilson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Wilson's Disease Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Wilson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Wilson's Disease Treatment Market Share by Application (2015-2020)
Table 76. Valeant Pharmaceuticals International. Inc. Company Details
Table 77. Valeant Pharmaceuticals International. Inc. Business Overview
Table 78. Valeant Pharmaceuticals International. Inc. Product
Table 79. Valeant Pharmaceuticals International. Inc. Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 80. Valeant Pharmaceuticals International. Inc. Recent Development
Table 81. Tsumura & Co Company Details
Table 82. Tsumura & Co Business Overview
Table 83. Tsumura & Co Product
Table 84. Tsumura & Co Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 85. Tsumura & Co Recent Development
Table 86. Merck & Co Company Details
Table 87. Merck & Co Business Overview
Table 88. Merck & Co Product
Table 89. Merck & Co Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 90. Merck & Co Recent Development
Table 91. VHB Life Science Inc. Company Details
Table 92. VHB Life Science Inc. Business Overview
Table 93. VHB Life Science Inc. Product
Table 94. VHB Life Science Inc. Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 95. VHB Life Science Inc. Recent Development
Table 96. Teva Pharmaceuticals USA, Inc Company Details
Table 97. Teva Pharmaceuticals USA, Inc Business Overview
Table 98. Teva Pharmaceuticals USA, Inc Product
Table 99. Teva Pharmaceuticals USA, Inc Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceuticals USA, Inc Recent Development
Table 101. Wilson's Therapeutics AB Company Details
Table 102. Wilson's Therapeutics AB Business Overview
Table 103. Wilson's Therapeutics AB Product
Table 104. Wilson's Therapeutics AB Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 105. Wilson's Therapeutics AB Recent Development
Table 106. Noble Pharma Co., Ltd Company Details
Table 107. Noble Pharma Co., Ltd Business Overview
Table 108. Noble Pharma Co., Ltd Product
Table 109. Noble Pharma Co., Ltd Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 110. Noble Pharma Co., Ltd Recent Development
Table 111. Kadmon Holding, Inc. Business Overview
Table 112. Kadmon Holding, Inc. Product
Table 113. Kadmon Holding, Inc. Company Details
Table 114. Kadmon Holding, Inc. Revenue in Wilson's Disease Treatment Business (2015-2020) (Million US$)
Table 115. Kadmon Holding, Inc. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wilson's Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. D-Penicillamine Features
Figure 3. Trientine Features
Figure 4. Tetrathiomolybdate Features
Figure 5. Others Features
Figure 6. Global Wilson's Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Wilson's Disease Treatment Report Years Considered
Figure 11. Global Wilson's Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Wilson's Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Wilson's Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Wilson's Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Wilson's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Wilson's Disease Treatment Revenue in 2019
Figure 18. North America Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Wilson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…- レイノー病治療の世界市場（～2026年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Raynauds Disease Treatment Scope and Market Size Raynauds Dis…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- ベーチェット病治療の世界市場（～2026年） Behcet disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. Market Analysis and Insights: Global Behcet Disease Treatment Market The global Behcet Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…